Somatostatin (SST) deficits are common pathological features in depression and other neurological disorders with mood disturbances, but little is known about the contribution of SST deficits to mood symptoms or causes of these deficits. Here we show that mice lacking SST (Sst KO ) exhibit elevated behavioral emotionality, high basal plasma corticosterone and reduced gene expression of Bdnf, Cortistatin and Gad67, together recapitulating behavioral, neuroendocrine and molecular features of human depression. Studies in Sst KO and heterozygous (Sst HZ ) mice show that elevated corticosterone is not sufficient to reproduce the behavioral phenotype, suggesting a putative role for Sst cell-specific molecular changes. Using laser capture microdissection, we show that cortical SST-positive interneurons display significantly greater transcriptome deregulations after chronic stress compared with pyramidal neurons. Protein translation through eukaryotic initiation factor 2 (EIF2) signaling, a pathway previously implicated in neurodegenerative diseases, was most affected and suppressed in stress-exposed SST neurons. We then show that activating EIF2 signaling through EIF2 kinase inhibition mitigated stress-induced behavioral emotionality in mice. Taken together, our data suggest that (1) low SST has a causal role in mood-related phenotypes, (2) deregulated EIF2-mediated protein translation may represent a mechanism for vulnerability of SST neurons and (3) that global EIF2 signaling has antidepressant/anxiolytic potential.
INTRODUCTION
Major depressive disorder (MDD) is a severe psychiatric disorder with a lifetime prevalence of 28-40%. 1 It is the leading cause of years lost because of disability worldwide in women and men, 2 reflecting a life-long trajectory of recurrent episodes, increasing severity and progressive treatment resistance. 3 MDD is a complex polygenic disease with highly heterogeneous clinical presentation and pathology. Therapeutic approaches rely mostly on compounds targeting the monoaminergic systems. However, even under optimal conditions, only one out two patients will experience remission from symptoms after antidepressant treatment. 4 Taken together, the heavy burden on society and individuals and its insufficient pharmacological treatment highlight the critical need for a better understanding of the primary pathophysiology of MDD, as a first step toward developing new therapeutic approaches.
Reduced levels of the inhibitory neuropeptide somatostatin (SST; also called SOM or SRIF) are frequently observed in individuals with MDD and other neurological disorders, regardless of categorical diagnosis. 5, 6 Human post-mortem studies from our group have described SST deficits in MDD patients, including a downregulation of SST gene expression in the dorsolateral prefrontal cortex, subgenual anterior cingulate cortex and amygdala. [7] [8] [9] [10] SST is coexpressed with γ-aminobutyric acid (GABA), and SST-expressing GABA neurons preferentially target the dendrites of pyramidal neurons. [11] [12] [13] Thus, it has been hypothesized that SST neurons regulate information input by providing spatiotemporal integration of postsynaptic potential in local cortical circuits. [14] [15] [16] Notably, two peptides colocalized with SST, neuropeptide Y (NPY) and cortistatin, are both significantly downregulated in the corticolimbic areas of MDD patients, 7, 10 further suggesting a potential role of disinhibition of the dendritic compartment of pyramidal neurons in mood dysregulation.
SST inhibits the release of numerous hormones from the hypothalamus, as confirmed by mice lacking SST (Sst KO ) displaying elevated circulating corticosterone. 17 Low SST levels were initially reported in the cerebrospinal fluid of MDD patients, [18] [19] [20] which negatively correlated with urinary cortisol levels. 21 These observations are consistent with altered hypothalamic-pituitary-adrenal (HPA) axis function described in some depressed patients, 22, 23 although its direct contribution to depression is still controversial. 24 Conversely, several pharmacological studies support the antistress role of SST on the endocrine, autonomic and visceral systems. 25 Intracerebroventricular administration of pan-SST agonist (ODT8-SST) in rats suppresses the stress-induced rise of adrenocorticotropic hormone, epinephrine and norepinephrine in the plasma. 26, 27 In addition, rats with intracisternal injection of ODT8-SST reduced stress-related inhibition of ghrelin, food intake and gastric emptying. 28 What could be the origin of reduced SST in MDD? Exposure to chronic stress is a leading risk factor associated with mood symptoms. 29 Biological stressors, such as seizure or electrical foot shock, can selectively affect SST interneurons or Sst expression. 30, 31 Studies in mice show that brain-derived neurotrophic factor (BDNF), a stress-sensitive growth factor, is necessary for the maintenance of normal expression of Sst, Npy and Cortistatin. 7, 9, [32] [33] [34] In humans, reduced BDNF signaling has been implicated in the pathophysiology of MDD through both peripheral and central measures. 7, 9, 35 Evidence for a causal role for SST in mood regulation is inconclusive at this point. Sst KO mice displayed a trend (P40.08) toward increased anxiety-like behaviors in the light-dark avoidance test but not in the open-field (OF) test (P40.3). 17 Albrecht 1 et al. 36 investigated Sst KO mice in 2 days of the dark cycle and found that unstressed Sst KO mice showed increased anxiety-like behaviors during the second day but not the first day of the active phase. 36 Microinjections of SST into the amygdala or ventricles exert anxiolytic effects in the elevated plus maze (EPM) test. 37, 38 Reducing SST neuronal function acutely and chronically in the frontal cortex yields opposite effects on behavioral emotionality, suggesting that mood regulation may depend on complex network adaptations including multiple regions and on the timeframe. 39 In addition, it is not known whether HPA axis dysregulation of Sst KO mice contributes to these behavioral changes.
As mood dysregulation represents the distal effect of complex interactions among multiple genes, brain systems and stressors, we speculate that global dysfunction of SST and SST neurons may contribute to altered neuroendocrine function and to aberrant inhibitory neurotransmission in local cortical circuits. Therefore, SST deficits could affect the function of key corticolimbic brain areas, prime the system for deregulated stress responses and induce physiological changes, together leading to mood dysregulation. To begin testing this hypothesis, we investigated here (1) whether global SST deficits in mice can cause behavioral, molecular and neuroendocrine phenotypes that are observed in depressed patients, and (2) how chronic stress may affect SST neurons.
MATERIALS AND METHODS
A complete description is found in the Supplementary Information.
Animals
All experiments were performed with 3-to 5 month-old male and female mice littermates, between 0900 and 1500 hours. All non-stressed control mice were group housed and maintained under standard conditions (12/12-h light-dark cycle, lights on at 0700 hours, 22 ± 1°C, with food and water ad libitum). All mice were on the C57BL/6J background. The Sst KO mouse line was obtained from the Jackson Laboratory (Bar Harbor, ME, USA; stock no. 008117). 17 Sst KO , Sst HZ and Sst WT littermates were generated by crossing Sst HZ mice. Genotyping was carried out by PCR analysis of DNA isolated from tail cuts. To generate mice with green fluorescent protein (GFP) expression in SST cells, the mouse line carrying an SST promoterdriven Cre recombinase expression (SST-ires-cre knock-in homozygous mice; Jackson Laboratory; stock no. 013044) was crossed with a Rosa GFPfloxed reporter mouse line carrying a loxP-flanked STOP cassette (Ai6 Rosa26-loxP-STOP-loxP-ZsGreen; Jackson Laboratory; stock no. 008242), as described previously. 40 Unpredictable chronic mild stress Mice were subjected to six weeks of a random schedule consisting of 1-3 environmental stressors per day, seven days per week. 41 The social isolation treatment began from the fifth week until the day of euthanasia. Mice typically exhibit robust physiological changes (i.e., coat state degradation) which plateau after 4 weeks, 41 and that can be exacerbated by social isolation. For the drug study (salubrinal and GSK2606414), we avoided the ceiling effects of unpredictable chronic mild stress (UCMS) on behavioral emotionality and used 4 weeks of UCMS treatment. Weekly assessment of weight and fur was performed to monitor physiological progression of the UCMS syndrome.
Behavior
Anxiety/depressive-like behaviors were tested in the EPM, OF, noveltysuppressed feeding (NSF) and sucrose preference test separated by a minimum of 1 day. All tests were performed during the light phase of the circadian cycle, between 0900 and 1500 hours, as described previously. 42 As the EPM test is considered the most sensitive test before behavioral testing, we started with EPM, followed by the other tests. To minimize stress of behavioral testing in the drug study and to avoid excess sucrose solution that might affect oral gavage of drug treatments, we performed EPM followed by NSF and OF. To assess the consistency of behavioral performance across related tests, emotionality-and locomotion-related data were integrated using a Z-score methodology. 43 
Corticosterone measurements
The stress reactivity test consisted of a 30-min restraint period, corresponding to an acute, moderate stressor. The blood samplings were drawn at three time points: immediately before, during a 30-min exposure to restraint stress and 60 min after ending the stress session (recovery period). The animals were restrained in a 50-ml Falcon tube with a ventilation hole and a hole in the lid for the tail. Tail blood (30 μl) was collected into a Microtainer tube with lithium heparin (BD Vacutainer Systems, Franklin Lakes, NJ, USA) at 1000-1400 hours. All samples were ran in duplicate and measured by Corticosterone ELISA Kit (Enzo Life Sciences, Farmingdale, NY, USA) according to the manufacturer's instructions.
Chronic corticosterone treatment
As described previously, 44 mice were given corticosterone (35 mg ml 
Visualization of individual neurons in mice
Mice were rapidly transcardially perfused with 1 ml of 1 × Tris-buffered saline and 1 ml of 4% paraformaldehyde in phosphate buffer (pH 7.4) to lightly fix tissue while preserving GFP signal and RNA integrity. Cryostat sections (14 μm) were cut from coronal blocks containing the cingulate cortex (between bregma +1.42 to − 0.5 mm), and then thaw mounted on polyethylene napthalate membrane-coated slides (no. 11505158; Leica Microsystems, Bannockburn, IL, USA) that had been treated with UV at 254 nm for 30 min. Before microdissection, slides for SST neurons were dehydrated through 100% ethanol for 10 s. For pyramidal neurons, cryostat sections from mice with GFP-tagged SST neurons were dried briefly and stored at − 80°C. Immediately before microdissection, slides were immersed in an ethanol-acetic acid fixation solution, stained with thionin and then dehydrated with 100% ethanol, as described previously. 45 Pyramidal neurons were visually identified based on their location and characteristic somal morphology, including pyramidal shape, large size and thick apical dendrite.
Laser microdissection and gene expression profiling
Laser microdissection was performed using a Leica LMD6500 system (Wetzlar, Germany; ×40 objective in the fluorescence mode for SST neurons or bright-field mode for pyramidal neurons). Cutting and collection steps were subsequently examined in fluorescent or brightfield mode. One hundred cells from the mouse cingulate cortex per animal were collected in 0.5 ml microtube caps (Ambion, Foster City, CA, USA) and lysed by vortexing for 30 s in 150 μl of RLT Buffer Plus (Qiagen, Valencia, CA, USA) within a 3-h time span, and stored at − 80°C until further processing. Total RNA was then extracted using the RNeasy Plus Micro Kit (Qiagen) according to the manufacturer's instructions. RNA samples were amplified with NuGEN ® Ovation Pico WTA System V2 (NuGen, San Carlos, CA, USA). The fragmented labeled cDNA samples were processed and hybridized to Affymetrix ® Mouse Gene 1.1 ST Array Plates (Affymetrix, Santa Clara, CA, USA). Gene expression information was obtained with the Affymetrix console software. Genes showing significant differences (Student's t-test Po0.005; 41.2-fold cutoff) in expression between SST neurons from stressed and unstressed mice were analyzed using the Ingenuity Pathway Canonical pathway analysis (IPA) software (Ingenuity Systems, Redwood, CA, USA).
Real-time qPCR
For molecular phenotypes in mice with low SST, brains were flash frozen on dry ice after killing. Bilateral cingulate cortex was obtained using a cryostat and a 1-mm-bore tissue punch. Total RNA was extracted using the RNeasy Micro Kit (Qiagen) according to the manufacturer's instructions. Reverse transcription reaction was performed using the qScript cDNA Supermix (Quanta Biosciences, Gaithersburg, MD, USA). The comparative threshold cycle (C t ) measurement was performed for quantification with SYBR green fluorescence signal (Invitrogen, Carlsbad, CA, USA), as described previously. 45 For single-cell analyses, total RNA from mouse cells were amplified with NuGEN ® Ovation Pico WTA System V2 (NuGen). Samples were run in triplicates and the difference in ΔC t values for each transcript was determined by comparison with a non-biased control gene, neurofilament.
RNAscope assay for in situ RNA detection 
Drug administration
The selective EIF2A phosphatase inhibitor complexes, Salubrinal (Millipore, Billerica, MA, USA), and the EIF2AK3/protein kinase RNA-like endoplasmic reticulum (PERK) inhibitor, GSK2606414 (Millipore), were dissolved in 100% dimethyl sulfoxide and later diluted in saline (0.9% NaCl). Based on previous studies, [46] [47] [48] vehicle (10% dimethyl sulfoxide/saline), Salubrinal (1.5 mg kg − 1 ) and GSK2606414 (30 mg kg − 1 ) were administered by oral gavage once daily for 7 days to mice (0.1 ml/10 mg) treated with 3 weeks of UCMS before behavioral testing. A separate group treated with GSK2606414 alone was used to assess the specificity of the drug, compared with non-stressed vehicle group. Three days of booster administrations were given on the second day after each test. Concentrations were adjusted to administer 10 ml kg − 1 . After 7 days of drug treatments, anxiety/depressive-like behaviors and locomotion were tested in the following order: EPM, NSF and OF separated by one day of booster administration. All tests were performed during the light phase of the circadian cycle, between 0900 and 1500 hours.
Statistical analysis
Statistical analyses were carried out using GraphPrism Version 6.0 (GraphPad Software, San Diego, CA, USA). Student's t-test was used to compare means between two groups, and one-way or two-way analysis of variance followed by Tukey's post hoc among means were used to determine significant differences among multiple groups. All data are expressed as means ± s.e.m.
RESULTS

Sst genetic ablation increases anxiety/depressive-like behaviors
To determine whether SST has a causal role in mood dysregulation, we used previously generated Sst KO mice. 17 Sst KO and wild-type (Sst WT ) littermates were submitted to several behavioral tests for measuring aspects of anxiety/depressive-like behaviors. To assess the consistency of behavioral performance over time and related assays, we also applied Z-normalization to integrate emotionality-related measures across tests, as described previously. 43 Here, the most robust findings were consistently observed in the NSF test, so we focus our report on this test, while also providing results from integrated emotionality Z-scores.
(Detailed results of all tests are provided in the supplements.) Under non-stressed baseline conditions, Sst KO mice showed increased latency to begin eating in the NSF compared with Sst WT mice ( Figure 1a ). Results were variable in other tests, displaying increased anxiety/depressive-like behaviors or no change (Supplementary Figure S1 ). Integrated Z-scores showed that Sst KO mice overall displayed significant elevated behavioral emotionality, when compared with Sst WT mice ( Figure 1a , left panel). Exposure to chronic stress is a main exogenous risk factor associated with elevated mood symptoms, 29 and the interaction of stress with genetic risk factors can increase susceptibility to mood dysregulation in humans. 49 UCMS is a paradigm that induces anxiety/depressive-like behaviors in rodents, as well as neuroendocrine and molecular changes otherwise associated with MDD. 50, 51 Hence, to investigate the effects of Sst ablation on behavioral emotionality in response to stress, we exposed the same cohort of Sst KO and Sst WT mice to UCMS. We observed a progressive degradation of the fur coat quality, indicating that both groups responded to UCMS (Figure 1a ). Behavioral testing in the last 2 weeks of the UCMS protocol revealed increased latency to feed in the NSF test and higher emotionality Z-scores in stressed Sst KO mice compared with stressed Sst WT mice (Figure 1a , right panel, and Supplementary Figures S1F and J) . Although normal variability in behavioral testing precludes comparison of absolute values across time in a longitudinal study design (baseline followed by post-UCMS behavioral testing), the results do not suggest any genotype by stress interaction. Instead, the results show that Sst KO mice maintained a similarly higher behavioral emotionality over Sst WT littermates under non-stressed (1.51 ± 0.17-fold (s.e.m.) relative to control) and stressed conditions (1.69 ± 0.11 fold (s.e.m.) relative to control).
To validate these findings, we investigated the behavioral emotionality of Sst KO mice in a second independent cohort of mice. Consistent with results described above, Sst KO mice displayed increased latency to feed in the NSF test compared with control Sst WT mice both at baseline (Po 0.01) and after UCMS exposure (P o 0.005; Supplementary Figure S2A ), demonstrating reliability across cohorts and time.
Based on a priori information of a putative sex difference (i.e., human studies), we separated the data by sex groups (male and female cohorts) and observed that the increased emotionality was more robust in female Sst KO mice under chronic stress conditions (Supplementary Figures S2B and C) . Note that there was no statistical interaction between sex and treatment, indicating that the results in female Sst KO mice were more robust rather than different from male Sst KO mice. These findings parallel the molecular findings in depressed patients, showing that downregulated SST levels in MDD patients are more robust in women, with similarly no evidence for a gender difference.
SST is involved in feeding behaviors, 52,53 thus we assessed the appetitive drive in the NSF paradigm by measuring the amount of food consumed in the home cage after NSF testing. In the first cohort, we observed a small but significant reduction in food consumption in Sst KO mice under baseline non-stressed conditions (Supplementary Figure S3) . This phenomenon was not observed after UCMS exposure (Supplementary Figure S3) . Using the second cohort in the replication study, we observed nonsignificant trends for reduced post-NSF food consumption (Supplementary Figure  S3) . Combining the two cohorts of Sst KO mice, there was no significant correlation between post-NSF food consumption and anxiety/depressive-like behaviors (i.e., latency to feed) during the NSF under baseline (r = − 0.05; P = 0.77) or UCMS-exposed (r = − 0.23; P = 0.24) conditions (Supplementary Figure S4A) . No significant correlation between home-cage food consumption and baseline/trait emotionality (r = 0.01, P = 0.95) or post-UCMSstate emotionality (r = 0.05, P = 0.81) was found in Sst KO mice (Supplementary Figure S4B) . In addition, Sst KO mice displayed normal body weight and general locomotion across tests and conditions, as demonstrated by the absence of significant differences in locomotion Z-scores (Figures 1b and c) , although Sst KO mice showed reduced locomotion in the OF after UCMS (Figure 1c ). Taken together, these control studies did not identify any consistent pattern of differences and thus suggest that the increased latency to feed in the NSF and the overall elevated behavioral emotionality of Sst KO mice were not confounded by physiological or activity changes (see Discussion).
Neuroendocrine function does not correlate with behavioral emotionality in Sst KO and Sst HZ mice
We next tested the putative role of HPA function in the regulation of the Sst KO phenotype. Consistent with early observations, 17 we report high basal plasma levels of corticosterone in Sst KO mice (Figure 1d ). We extended these findings and showed that heterozygous (Sst HZ ) mice displayed similar elevated corticosterone levels (Figure 1d ). After 30 min of acute restraint stress or 1 h of recovery from stress, corticosterone levels were not different among Sst WT Figure S5) under baseline conditions. Similarly, after UCMS treatment, behaviors of stressed Sst HZ mice were not different from stressed Sst WT littermates (Supplementary Figure S5) .
Taken together, these observations indicate that the elevated levels of corticosterone observed in Sst KO and Sst HZ mice are potential biomarkers of low SST but not systematically associated with measures of behavioral emotionality. Although we cannot rule out a partial contribution of corticosterone to the high emotionality phenotype in Sst KO mice, results in Sst HZ mice indicated that high corticosterone levels were not sufficient to increase behavioral emotionality. Indeed, these results also suggest the presence of compensatory mechanisms in Sst HZ mice or additional regulatory mechanisms in Sst KO mice.
GABA-related gene expression in Sst KO mice recreate a dysregulated profile reported in human depression SST is a marker of dendritic-targeting GABA neurons, which partly overlaps with NPY and cortistatin (CORT), and which contains the 67 kDa isoform of GABA-synthesizing enzyme glutamic acid decarboxylase (GAD67), together contributing the majority of inhibitory input onto pyramidal dendrites. 54, 55 Expression of these GABA-related markers is downregulated in the anterior cingulate cortex and amygdala of depressed patients, and in mice with reduced BDNF, 7,9,10 suggesting a vulnerable BDNF/GABA-enriched gene module in SST neurons associated with mood regulation. To examine whether loss of SST affected this particular gene module, we performed quantitative PCR (qPCR) to measure gene expression in the cingulate cortex of mice with low SST. We showed that when compared with Sst WT mice, Sst ablation resulted in low expression of Cort, Bdnf and Gad67 (Table 1) , hence mimicking key gene changes observed in mice with altered BDNF function and in depressed patients (Table 1) . On the other hand, Sst HZ mice showed unchanged Npy and Gad67 expression, reduced Bdnf expression, but increased Cort expression ( Table 1) . As Cort binds to all SST receptors and shares structural, functional and pharmacological properties with SST, including inhibitory neuromodulation, 56 we speculate that upregulation in Cort may compensate for the absence of Sst and contribute to the normal behavioral emotionality in Sst HZ mice. It is notable that although BDNF is a known upstream regulator of SST expression, the results show that reduced BDNF expression can also occur downstream from reduced SST expression, demonstrating bi-directional regulatory links. It is also possible that elevated levels of corticosterone in mice with low SST may lead to reduced BDNF expression. Taken together, the integrated results indicate that Sst KO mice recapitulate behavioral (high emotionality), molecular (downregulated expression of BDNF/GABA-enriched gene module) and neuroendocrine (high corticosterone) phenotypes that are observed in depressed patients.
Stress affects the transcriptome of SST-positive neurons but not pyramidal cells
To investigate whether the above-described changes in a BDNF/ GABA/SST gene module corresponded to broader molecular changes in SST neurons, we applied UCMS to mice expressing GFP in SST neurons, captured GFP-positive SST neurons and thionin-stained pyramidal neurons from cingulate cortex using laser capture microdissection, and analyzed RNA profiles using Affymetrix Gene 1.1 ST microarrays (Figure 2a) . Frequency histograms demonstrate striking differences between the effects of stress on SST neurons (Figures 2b and c, red bars) and pyramidal neurons (Figures 2b and c , black bars) (Kolmogorov-Smirnov test, P oE − 15). Specifically, UCMS-induced changes in a large proportion of the transcriptome in SST neurons, as shown by frequency distributions in the histograms of effect sizes (Figure 2b ) and statistical significance (Figure 2c ). The shifted distributions of effect size (to left) and statistical significance (to right) were mostly characterized by downregulated expression. In addition, we also examined the transcriptome profiles of two other types of interneurons that are partially colocalized with SST after chronic exposure to UCMS or corticosterone, including NPY and cortistatin-containing neurons. Interestingly, we observe very mild changes in gene expression in these two GABA neuron subpopulations (data not shown). This indicates a heterogeneous vulnerability of those related cell populations, and suggests that changes in SST neurons per se may be the critical biological event associated with heightened cellular stress and behavioral emotionality. Among those UCMS-affected genes in SST neurons were Sst and Gad67. The array results were confirmed by independent qPCR assays (Figure 2d ). In contrast, we observed small and nonsignificant changes of gene expression in pyramidal neurons from UCMS-exposed mice (Figures 2b and c, black bars) . Taken together, the results demonstrated a selective cellular vulnerability of SST neurons to stress. Stress links SST neuron deficits to EIF2 signaling To assess the biological implications of the transcriptome results, we applied IPA on the sets of differentially expressed genes at various stringency levels. IPA results indicated a common enrichment of affected protein translation initiation and mitochondrial functions. Under moderate stringency (changes ⩾ 20%; P o0.005), the EIF2 pathway was the most significantly affected (P = 7.38E − 21) with multiple downregulated genes in SST neurons of UCMS-treated mice (Table 2 and Supplementary Table S1 ). Results were highly similar across different cutoff ranges. Here we showed that Sst expression was highly correlated with EIF2α subunit (Eif2a) expression (Supplementary Figure S6A) , suggesting that EIF2A may be associated with SST deficits. Downregulation of Eif2a expression in SST neurons from UCMS-exposed mice was validated by qPCR in tissue extracts (Supplementary Figure S6B) and RNAScope in situ hybridization on tissue sections (Supplementary Figure S6C) .
EIF2 signaling has a crucial role in protein translation initiation by binding the initiator methionyl-tRNA Met to the 40S ribosomal subunit for forming the preinitiation complex. In response to cellular stress, increasing levels of misfolded/damaged proteins can initiate the unfolded protein response (UPR) to suppress EIF2 signaling, which blocks protein translation as a protective cellular mechanism. Several brain disorders have been associated with suppression of protein translation through phosphorylation of EIF2A, including Alzheimer's and Parkinson's diseases, and animal models of Alzheimer's disease, prion disease and amyotrophic lateral sclerosis. 46, 48, 57 Here, applying an upstream regulator prediction analysis in IPA, 58 we found that the top regulators have been previously associated with neurodegenerative diseases (e.g., MAPT, APP, PSEN1, HTT; Supplementary Table S2) , together suggesting a similar mechanism of deregulated protein homeostasis (proteostasis) underlying heightened vulnerability of neurons across neurological diseases. Hence, these results provide additional putative links between stress-induced SST deficits and neurodegenerative processes, as least though these in silico analyses.
We next sought to independently validate these transcriptome results. As we cannot completely rule out a contribution of elevated corticosterone to the phenotypes of Sst KO mice, and chronic elevated corticosterone exposure can induce anxiety/ depressive-like behaviors in mice, 44, 59 we speculated that SST neurons might be similarly vulnerable to elevated glucocorticoids, albeit to a lower extent than to UCMS exposure. Thus, in a parallel study, we performed similar single-cell analyses for SST neurons in mice chronically exposed to corticosterone. We found that chronic corticosterone exposure induced transcriptome alterations in SST neurons that were highly similar to changes observed after UCMS (Pearson's correlation, r = 0.82; P = 10 − 7 ), although with reduced effect sizes (slope = 0.48; i.e.,~50% of UCMS effect size; Supplementary Figure S7A ). Similar to UCMS results, very few gene changes were observed in pyramidal neurons compared with SST neurons following corticosterone exposure (Kolmogorov-Smirnov test, P o E − 15; Supplementary Figures S7B and C) , suggesting a similarly selective vulnerability of SST neurons to a neuroendocrine stressor. Notably, the EIF2 pathway was the most significantly affected function in SST neurons following chronic corticosterone treatment, although this result was observed at much less stringent statistical thresholds compared with results after UCMS exposure (changes ⩾ 20%; P o0.05; IPA P = 0.000463; Supplementary Table S2 ). It suggests a central role for EIF2 signaling in response to stress.
Chronic corticosterone exerted similar but greatly reduced impact on gene changes in SST neurons, and also showed minimal effects on pyramidal neurons (Supplementary Figures S7A) , hence confirming the elevated vulnerability of SST neurons. These results are also consistent with a non-sufficient role for the elevated baseline corticosterone of Sst KO and Sst HZ mice in increasing behavioral emotionality.
EIF2 kinase inhibition blocks the development of stress-induced anxiety/depressive-like behaviors One arm of this UPR pathway leads to the phosphorylation of PERK and its downstream effector, EIF2A. EIF2A phosphorylation is a well-known mechanism to suppress protein synthesis in response to cellular stress and is thought to protect cells against stress-induced apoptosis. 60 Systemic modulation of EIF2A phosphorylation affects TDP-43 toxicity in mouse models of amyotrophic lateral sclerosis, neurodegeneration in prion-infected mice and cognitive function in mouse models of Alzheimer's disease without overt side effects. [46] [47] [48] 61 Compounds that inhibit EIF2A kinase or phosphatase have been validated for optimal use in mice, including for brain-related targets. [46] [47] [48] 61 Accordingly, we predicted that stress-induced anxiety/depressive-like behaviors would be affected by compounds that target the EIF2 pathway. Salubrinal is an inducer of EIF2A phosphorylation via inhibition of EIF2A phosphatase, 62 that is, activating the cellular stress response and mimicking the disease effects. GSK2606414 is an inhibitor of EIF2A phosphorylation via inhibition of PERK, an EIF2 kinase, 63 that is, inhibiting the cellular stress response and potentially exerting therapeutic/antidepressant-like effects.
Results showed that, as predicted, anxiety/depressive-like behaviors in the NSF (Figure 3b ) and overall emotionality (Figure 3c ) increased after UCMS treatment in vehicle-treated mice. We found that UCMS-exposed mice treated with GSK2606414 displayed significantly less UCMS-induced anxiety/ depressive-like behaviors in the NSF (Figure 3b ) and emotionality Z-scores (Figure 3c ) compared with the vehicle-treated stressed mice. Salubrinal did not significantly exacerbate UCMS-induced anxiety/depressive-like behaviors, suggesting either no effect of salubrinal at a 1.5 mg kg − 1 dose or a ceiling effect of stress on behavioral emotionality. Locomotion (Figure 3d ), weight ( Figure 3e ) and post-NSF food consumption (Figure 3f) were not affected by drug treatments. Consistent with previous observations, there was no significant correlation between post-NSF food consumption and latency to feed after NSF (r = − 0.10; P = 0.52). A group treated with GSK2606414 alone did not display any phenotypes as compared with control vehicle mice, including behavioral emotionality, post-NSF feeding, locomotion or weight changes (Supplementary Figure S8) . Taken together, the results Abbreviations: IPA, Ingenuity Pathway Canonical pathway analysis; UCMS, unpredictable chronic mild stress. Genes were tested for differential expression between UCMS and control groups. Selected genes (fold-change 420%; Po 0.005) were submitted to IPA to test for overrepresentation of canonical pathways. P-value was calculated by righttailed Fisher's exact tests. The ratio was calculated by the number of differentially expressed genes divided by the total number of genes that make up a given pathway.
suggest that activating the EIF2 pathway through EIF2 kinase inhibition may relieve stress-related mood disturbances.
DISCUSSION
We report behavioral alterations, and aberrant molecular and neuroendocrine phenotypes in Sst KO mice, which are consistent with changes frequently observed in MDD patients. Studies in Sst KO and Sst HZ mice show that elevated corticosterone is not sufficient to reproduce the behavioral phenotype, suggesting a putative role for Sst cell-specific molecular changes. Gene expression of multiple components of the translational machinery, especially the EIF2 signaling pathway, was suppressed in SST neurons across two murine stress models, and the extent of these changes paralleled behavioral changes. Activation of the EIF2 pathway reversed the elevated behavioral emotionality in mice exposed to chronic stress. Collectively, our data provide evidence in support of a causal role for SST deficits in the mood component of MDD, and suggest a mechanism of deregulated EIF2-mediated protein translation as a critical gateway for vulnerability of SST neurons and behavioral emotionality to chronic stress.
SST in mood regulation Human post-mortem brain studies have reported SST deficits in depression and other neurological disorders, 5, 6 raising the possibility that altered functions of SST interneurons, associated neuroendocrine and cortical local circuit regulation may represent common pathophysiological features associated with mood dysregulation across disorders. 5 Although direct evidence for causality is not achievable with human studies alone, we now report elevated behavioral emotionality in Sst KO mice under baseline and chronic stress conditions (Figure 1 and Supplementary Figure S1 ). Specifically, the increased latency to feed in the NSF test is typically interpreted as elevated anxiety/depressive-like behaviors, as it can be reversed by chronic but not acute antidepressant treatment. 64 These results were independently replicated in a second cohort of mice. Sst KO mice displayed variability in behaviors across other behavioral tests, but consistently in the same direction, together resulting in significantly elevated emotionality Z-scores in both cohorts (Figure 1 and Supplementary Figure S1 and S2). The reason for the more robust phenotypic result of Sst KO mice in the NSF test is not known. It may reflect the fact that this test captures a different component of mood regulation or engages slightly different biological and neural network regulation. 44 Zeyda et al. 17 did not report significant changes in behavioral emotionality in Sst KO mice, but nominal trends were observed in some of the performed tests and they did not use the NSF test. In addition, Sst KO mice were maintained on a 129/Sv background in that previous study, compared with the C57BL/6J background used here, and mice were previously only investigated under non-stressed baseline conditions. Thus, variations in behavioral phenotype, genetic background and stress state may underlie those discrepancies.
Despite the limitations of a global KO, Sst KO mice provide an opportunity to explore the causal role of SST in mood dysregulation and the underlying neural mechanisms. Such insights, however, will need to be refined with a systematic behavioral characterization with fine spatial and temporal resolution, using region-specific manipulations at different developmental stages. Studies will then need to assess the molecular and cellular systems that SST manipulations converge upon, and where the exact neural circuits are affected.
Neuroendocrine and molecular correlates of depression in Sst KO mice Altered HPA axis function commonly occurs in depression, and includes increased cortisol and abnormal dexamethasone suppression. 65 Previous investigations in the role of low SST in depression have largely focused on its neuroendocrine function, as SST inhibits the release of several hormones from the hypothalamus and pituitary gland. 66 Our data confirm that SST deficits are an important causal factor leading to HPA axis hyperactivity, as high plasma levels of corticosterone were measured in Sst HZ and Sst KO mice. However, Sst HZ mice exhibited normal behavioral emotionality, indicating that high corticosterone is not sufficient to induce elevated behavioral emotionality, at least under the conditions of this study. Corticosterone is implicated in the organization of daily-related events such as sleep and body growth, 67 thus follow-up studies investigating the circadian patterns of corticosterone in mice with low SST may uncover more subtle phenotypes in Sst HZ and Sst KO mice. The anterior cingulate cortex is a key brain area involved in mood regulation, where emotional information integrates with cognitive control. 68, 69 Changes in the cingulate cortex activity have been implicated in depression and anxiety disorders, 69, 70 and in regulating homologous behaviors in mice. 71 On the molecular level, SST ablation induced changes in the cingulate cortex of Sst KO mice, including low Bdnf, Gad67 and Cort. These results suggest impairments in neurotrophic supply and GABAergic inhibition, which is reminiscent of observations in the cingulate cortex of depressed patients. The Sst KO molecular phenotype did not extend to other related GABA markers (i.e., NPY) identified in depression, suggesting additional mechanisms at play in the human condition. [7] [8] [9] [10] In contrast to previous studies, 17, 72, 73 we report downregulated Cort mRNA levels in the cingulate cortex of Sst KO mice but upregulated in Sst HZ mice. Cort shares structural, functional and pharmacological properties with SST and binds to all SST receptors. 56 Thus, we speculate that upregulated Cort levels may compensate for low Sst function in Sst HZ mice, and that additional and different mechanisms are engaged in the full KO, including reduced GABA function, as low Gad67 was observed in Sst KO but not in Sst HZ mice. Notably, the fact that Sst KO , and not SSst HZ mice, replicate the behavioral and molecular profiles of the illness is not uncommon in rodent studies, as the pathology of MDD is thought to include multiple molecular deregulations in addition to reduced Sst deregulations and that more robust changes (as in full KO) may be needed in rodent models. Finally, the observation of downregulated Bdnf expression in Sst HZ and Sst KO mice is intriguing and worth noting as Bdnf is mostly characterized as an upstream regulator of SST expression. 7 Taken together, our results uncover subtle and complex homeostatic changes that are likely to affect the inhibitory function of local cortical circuits, potentially reflected in an altered mood-related network in the anterior cingulate cortex of MDD patients.
Biological vulnerability of SST neurons involves the Eif2a pathway We exposed mice to two different stress models, UCMS, an environmental/social/psychological stress and chronic corticosterone exposure, a neuroendocrine stress. Although both models lead to neuroendocrine-, physical-and behavioral depression-like alterations, UCMS has better construct, face and overall mechanistic validity compared with corticosterone exposure as social-environmental stress induces multisystems disruption that are not limited to neuroendocrine changes. 74, 75 Accordingly, our results show that UCMS elicited similar but larger transcriptome alterations in SST neurons compared with chronic corticosterone exposure. Out of the large number of stress-induced molecular changes, suppression of EIF2 signaling in stressed SST neurons was most prominent in both stress models, as reflected by the downregulated expression of many genes within this pathway. EIF2 signaling decreases protein translation in response to cellular stress. Extracellular stimuli and fluctuations in intracellular homeostasis modulate endoplasmic reticulum protein-folding status. The UPR activation is a general translational repression that is induced by endoplasmic reticulum stress. A molecular mediator of this pathway is phosphorylation of PERK, which in turn phosphorylates EIF2A, leading to a general inhibition of protein synthesis. 76 Notably, UPR-ER-EIF2 signaling has been implicated in the selective vulnerability of specific neurons in models of neurodegenerative diseases, including striatal neurons in Huntington's disease, motor neurons in amyotrophic lateral sclerosis mice and dopaminergic neurons in Parkinson's disease. [77] [78] [79] [80] Our results now implicate this pathway for the first time in mechanisms of cellular vulnerability of SST neurons in the context of major depression. Depression and other neuropsychiatric disorders are typically not considered neurodegenerative but rather neuroprogressive disorders that promotes brain rewiring and vulnerability to life stress. We speculate here that related basic cellular mechanisms may link both sets of disorders, consistent with the fact that SST deficits are commonly seen in neurodegenerative and neuropsychiatric diseases.
Finally, the stress-induced dysfunctions of SST and pyramidal cell may take many forms, including activity changes (i.e., electrophysiological properties), which were not measured here. Future studies will need to investigate those changes under both baseline and stressed conditions, and to determine the conditions under which aberrant EIF2 signaling and neuronal activity are mechanistically related. Therapeutic implications and conclusion Our studies using Sst KO mice demonstrate that the lack of Sst induces downregulation of Bdnf and GABA-related gene expression, elevated stress hormones and a behavioral phenotype consistent with elevated anxiety-and/or a depressive-like syndrome (denoted as behavioral emotionality). Moreover chronic stress-induced large-scale molecular changes in cingulate cortex SST neurons specifically highlighted a compromised EIF2 signaling. Prolonged suppression of EIF2 signaling alters proteostasis and cell function. We speculate that suppression of EIF2 signaling in stressed SST neurons may represent an early adaptive mechanism to reduce the burden of destabilized proteins associated with increased recruitment of these neurons during stress. This putative pathological mechanism is consistent with the frequent report of reduced SST expression observed across those disorders. UPR-ER-EIF2 signaling regulates secretory cell function, 81 and expression of secretory GABAergic markers, including SST and NPY through BDNF signaling. 82, 83 In our rodent model, we show that a 1 week treatment with a PERK inhibitor was sufficient to mitigate anxiety/depressive-like behaviors induced by chronic stress. This finding raises the intriguing possibility that boosting protein translation capacity of stressed SST neurons to maintain normal function and induce a routine protective response, such as upregulation of stress-responsive genes (e.g., SST-GABA signaling), may avoid the negative cellular effects of stress in SST neurons, which in turn may maintain appropriate local cortical circuit function in a mood regulatory neural network. In line with this hypothesis, EIF2 kinase inhibitor treatment reversed cellular and behavioral abnormalities in mouse models of several neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis and prion disease. 46, 48, 61 There are four known kinases, GCN2, PKR, PERK and HRI, which can phosphorylate EIF2A. Interestingly, the potential role of these EIF2A kinases in mood disorders is not known. Only two related studies have used PERK or PKR KO mice, and results indicated normal anxiety levels in the EPM and OF. 84, 85 However, these preliminary studies will need to be followed by full behavioral assessment under baseline and stressed conditions, and by spatial and temporal genetic manipulations. Several specific biochemical, cellular and neural activation steps are involved between blocking the activation of the UPR and the behavioral responses. Although beyond the scope of this study, delineating the different EIF2 signaling branches of UPR in specific cellular types and brain regions with specificity and timing (temporal vs chronic) of the pharmacological manipulations will form the basis of follow-up studies of symptom domains in neurological disorders.
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